يعرض 1 - 10 نتائج من 95 نتيجة بحث عن '"Zanaletti, N."', وقت الاستعلام: 1.40s تنقيح النتائج
  1. 1
    دورية أكاديمية
    Codon-specific KRAS mutations predict survival benefit of trifluridine/tipiracil in metastatic colorectal cancer.

    المؤلفون: van de Haar, J, Ma, X, Ooft, SN, van der Helm, PW, Hoes, LR, Mainardi, S, Pinato, DJ, Sun, K, Salvatore, L, Tortora, G, Zurlo, IV, Leo, S, Giampieri, R, Berardi, R, Gelsomino, F, Merz, V, Mazzuca, F, Antonuzzo, L, Rosati, G, Stavraka, C, Ross, P, Rodriquenz, MG, Pavarana, M, Messina, C, Iveson, T, Zoratto, F, Thomas, A, Fenocchio, E, Ratti, M, Depetris, I, Cergnul, M, Morelli, C, Libertini, M, Parisi, A, De Tursi, M, Zanaletti, N, Garrone, O, Graham, J, Longarini, R, Gobba, SM, Petrillo, A, Tamburini, E, La Verde, N, Petrelli, F, Ricci, V, Wessels, LFA, Ghidini, M, Cortellini, A, Voest, EE, Valeri, N

    المساهمون: Valeri, Nicola

    مصطلحات موضوعية: Humans, Proto-Oncogene Proteins p21(ras), Uracil, Trifluridine, Colorectal Neoplasms, Frontotemporal Dementia, Pyrrolidines, Colonic Neoplasms, Rectal Neoplasms, Drug Combinations, Mutation, Antineoplastic Combined Chemotherapy Protocols

    جغرافية الموضوع: United States

    وصف الملف: Print-Electronic; 614; application/pdf

    العلاقة: Nature Medicine, 2023, 29 (3), pp. 605 - 614; https://repository.icr.ac.uk/handle/internal/5808Test

    الإتاحة: https://doi.org/10.1038/s41591-023-02240-8Test
    https://repository.icr.ac.uk/handle/internal/5808Test

    View record in BASE

    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    Regorafenib monotherapy as second-line treatment of patients with RAS-mutant advanced colorectal cancer (STREAM): an academic, multicenter, single-arm, two-stage, phase II study

    المؤلفون: Cardone, C., De Stefano, A., Rosati, G., Cassata, A., Silvestro, L., Borrelli, M., Di Gennaro, E., Romano, C., Nappi, A., Zanaletti, N., Foschini, F., Casaretti, R., Tatangelo, F., Lastoria, S., Raddi, M., Bilancia, D., Granata, V., Setola, S., Petrillo, A., Vitagliano, C., Gargiulo, P., Arenare, L., Febbraro, A., Martinelli, E., Ciardiello, F., Delrio, P., Budillon, A., Piccirillo, M.C., Avallone, A.

    المساهمون: Bayer

    المصدر: ESMO Open ; volume 8, issue 1, page 100748 ; ISSN 2059-7029

    مصطلحات موضوعية: Cancer Research, Oncology

    الإتاحة: https://doi.org/10.1016/j.esmoop.2022.100748Test
    https://api.elsevier.com/content/article/PII:S2059702922003829?httpAccept=text/xmlTest
    https://api.elsevier.com/content/article/PII:S2059702922003829?httpAccept=text/plainTest

    View record in BASE

    أضف إلى المفضلة
  3. 3
    دورية أكاديمية
    Immunotherapy may protect cancer patients from SARS-CoV-2 infection: a single-center retrospective analysis

    المؤلفون: Isgro, MA, Vitale, MG, Celentano, E, Nocerino, F, Porciello, G, Curvietto, M, Mallardo, D, Montagnese, C, Russo, L, Zanaletti, N, Avallone, A, Pensabene, M, De Laurentiis, M, Centonze, S, Pignata, S, Cannella, L, Morabito, A, Caponigro, F, Botti, G, Masucci, GV, Giannarelli, D, Cavalcanti, E, Ascierto, PA

    المصدر: Journal of translational medicine. 19(1):132

    مصطلحات موضوعية: Medicin och hälsovetenskap

    الوصول الحر: http://kipublications.ki.se/Default.aspx?queryparsed=id:146373194Test

    View record in SwePub النص الكامل

    أضف إلى المفضلة
  4. 4
    دورية أكاديمية
    P-68 Regorafenib monotherapy as second-line treatment of patients with RAS-mutant advanced colorectal cancer (STREAM): An academic, multicenter, single-arm, two-stage, phase 2 study

    المؤلفون: Cardone, C., Piccirillo, M., Rosati, G., De Stefano, A., Romano, C., Nappi, A., Zanaletti, N., Foschini, F., Cassata, A., Casaretti, R., Silvestro, L., Tatangelo, F., Lastoria, S., Raddi, M., Bilancia, D., Febbraro, A., Martinelli, E., Ciardiello, F., Delrio, P., Perrone, F., Budillon, A., Avallone, A.

    المصدر: Annals of Oncology ; volume 33, page S271 ; ISSN 0923-7534

    مصطلحات موضوعية: Oncology, Hematology

    الإتاحة: https://doi.org/10.1016/j.annonc.2022.04.158Test
    https://api.elsevier.com/content/article/PII:S0923753422008481?httpAccept=text/xmlTest
    https://api.elsevier.com/content/article/PII:S0923753422008481?httpAccept=text/plainTest

    View record in BASE

    أضف إلى المفضلة
  5. 5
    دورية أكاديمية
    Clinicians’ Attitude to Doublet Plus Anti-EGFR Versus Triplet Plus Bevacizumab as First-line Treatment in Left-Sided RAS and BRAF Wild-Type Metastatic Colorectal Cancer Patients: A Multicenter, “Real-Life”, Case-Control Study

    المؤلفون: Parisi A., Porzio G., Cannita K., Venditti O., Avallone A., Filippi R., Salvatore L., Tortora G., Ribelli M., Nigro O., Gelsomino F., Spallanzani A., Zurlo V., Leo S., Dell'Aquila E., Claudia F., Lombardi P., Keranen S. R., Aimar G., Depetris I., Giampieri R., Morelli C., De Tursi M., Tinari N., Di Pietro F. R., De Galitiis F., Zanaletti N., Troiani T., Vitale P., Garajova I., Ghidini M., Spinelli G. P., Zoratto F., Roberto M., Ierino D., Petrillo A., D'Orazio C., Ficorella C., Cortellini A.

    المساهمون: Parisi, A., Porzio, G., Cannita, K., Venditti, O., Avallone, A., Filippi, R., Salvatore, L., Tortora, G., Ribelli, M., Nigro, O., Gelsomino, F., Spallanzani, A., Zurlo, V., Leo, S., Dell'Aquila, E., Claudia, F., Lombardi, P., Keranen, S. R., Aimar, G., Depetris, I., Giampieri, R., Morelli, C., De Tursi, M., Tinari, N., Di Pietro, F. R., De Galitiis, F., Zanaletti, N., Troiani, T., Vitale, P., Garajova, I., Ghidini, M., Spinelli, G. P., Zoratto, F., Roberto, M., Ierino, D., Petrillo, A., D'Orazio, C., Ficorella, C., Cortellini, A.

    مصطلحات موضوعية: Cetuximab, FOLFIRI, FOLFOX, FOLFOXIRI, mCRC, Panitumumab

    وصف الملف: STAMPA

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/34380594; info:eu-repo/semantics/altIdentifier/wos/WOS:000731861000014; firstpage:1; lastpage:8; numberofpages:8; journal:CLINICAL COLORECTAL CANCER; http://hdl.handle.net/11564/760327Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85112154399

    الإتاحة: https://doi.org/10.1016/j.clcc.2021.07.003Test
    http://hdl.handle.net/11564/760327Test

    View record in BASE

    أضف إلى المفضلة
  6. 6
    دورية أكاديمية
    Evaluation of second-line anti-VEGF after first-line anti-EGFR based therapy in RAS wild-type metastatic colorectal cancer. The multicenter “SLAVE” study

    المؤلفون: Parisi A., Cortellini A., Cannita K., Venditti O., Camarda F., Calegari M. A., Salvatore L., Tortora G., Rossini D., Germani M. M., Boccaccino A., Dell'aquila E., Fulgenzi C., Santini D., De Tursi M., Tinari N., Di Marino P., Lombardi P., Keranen S. R., Alvaro M. H., Zurlo I. V., Corsi D. C., Emiliani A., Zanaletti N., Troiani T., Vitale P., Giampieri R., Merloni F., Occhipinti M., Marchetti P., Roberto M., Mazzuca F., Ghidini M., Indini A., Garajova I., Zoratto F., Monache S. D., Porzio G., Ficorella C.

    المساهمون: Parisi, A., Cortellini, A., Cannita, K., Venditti, O., Camarda, F., Calegari, M. A., Salvatore, L., Tortora, G., Rossini, D., Germani, M. M., Boccaccino, A., Dell'Aquila, E., Fulgenzi, C., Santini, D., De Tursi, M., Tinari, N., Di Marino, P., Lombardi, P., Keranen, S. R., Alvaro, M. H., Zurlo, I. V., Corsi, D. C., Emiliani, A., Zanaletti, N., Troiani, T., Vitale, P., Giampieri, R., Merloni, F., Occhipinti, M., Marchetti, P., Roberto, M., Mazzuca, F., Ghidini, M., Indini, A., Garajova, I., Zoratto, F., Monache, S. D., Porzio, G., Ficorella, C.

    مصطلحات موضوعية: aflibercept, anti-angiogenic, bevacizumab, cetuximab, panitumumab, ras wild-type mcrc, second-line treatment

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/32429380; info:eu-repo/semantics/altIdentifier/wos/WOS:000539246000200; volume:12; issue:5; firstpage:1; lastpage:14; numberofpages:14; journal:CANCERS; http://hdl.handle.net/11573/1455905Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85085143774

    الإتاحة: https://doi.org/10.3390/cancers12051259Test
    http://hdl.handle.net/11573/1455905Test

    View record in BASE

    أضف إلى المفضلة
  7. 7
    دورية أكاديمية
    15P A pivotal multicenter translational research project on malignant pleural mesothelioma (MPM): Preliminary results

    المؤلفون: Di Liello, R., Della Corte, C.M., Ciaramella, V., Insa, A., Compañ-Quilis, D., Alonso, G., Borrás, R., Viscardi, G., Zanaletti, N., Sparano, F., Cozzolino, I., Montella, M., Vicidomini, G., Pastor-Escartín, I., Santini, M., Franco, R., Ciardiello, F., Martín-Martorell, P., Morgillo, F.

    المصدر: Annals of Oncology ; volume 32, page S7 ; ISSN 0923-7534

    مصطلحات موضوعية: Oncology, Hematology

    الإتاحة: https://doi.org/10.1016/j.annonc.2021.01.028Test
    https://api.elsevier.com/content/article/PII:S0923753421000375?httpAccept=text/xmlTest
    https://api.elsevier.com/content/article/PII:S0923753421000375?httpAccept=text/plainTest

    View record in BASE

    أضف إلى المفضلة
  8. 8
    دورية أكاديمية
    P-198 Prevalence of deleterious DPYD variants in patients with gastrointestinal malignancies: Real-world data from a single institution in Italy

    المؤلفون: Cardone, C., Collina, F., Brogna, M., Casaretti, R., Cassata, A., De Stefano, A., Di Giovanni, I., Nappi, A., Romano, C., Silvestro, L., Viscardi, G., Zanaletti, N., Di Bonito, M., Avallone, A.

    المصدر: Annals of Oncology ; volume 32, page S167 ; ISSN 0923-7534

    مصطلحات موضوعية: Oncology, Hematology

    الإتاحة: https://doi.org/10.1016/j.annonc.2021.05.253Test
    https://api.elsevier.com/content/article/PII:S0923753421014423?httpAccept=text/xmlTest
    https://api.elsevier.com/content/article/PII:S0923753421014423?httpAccept=text/plainTest

    View record in BASE

    أضف إلى المفضلة
  9. 9
    دورية أكاديمية
    491P Neoadjuvant nivolumab in early stage colorectal cancer

    المؤلفون: Avallone, A., De Stefano, A., Pace, U., Catteau, A., Di Gennaro, E., Tatangelo, F., Boquet, I., Cassata, A., Costantini, S., De Franciscis, S., Collina, F., Zanaletti, N., Vitagliano, C., Granata, V., Giannarelli, D., Lastoria, S., Ascierto, P.A., Galon, J., Delrio, P., Budillon, A.

    المصدر: Annals of Oncology ; volume 31, page S449 ; ISSN 0923-7534

    مصطلحات موضوعية: Oncology, Hematology

    الإتاحة: https://doi.org/10.1016/j.annonc.2020.08.602Test
    https://api.elsevier.com/content/article/PII:S0923753420405988?httpAccept=text/xmlTest
    https://api.elsevier.com/content/article/PII:S0923753420405988?httpAccept=text/plainTest

    View record in BASE

    أضف إلى المفضلة
  10. 10
    دورية أكاديمية
    13P Synergistic activity of PARP inhibitor and ATR inhibitor in melanoma cell lines may depend on BRAF-V600 mutation status

    المؤلفون: Giunta, E.F., Belli, V., Napolitano, S., De Falco, V., Vitiello, P.P., Terminiello, M., Caputo, V., Vitale, P., Zanaletti, N., Ciardiello, D., Argenziano, G., Martinelli, E., Martini, G., Troiani, T.

    المصدر: Annals of Oncology ; volume 31, page S248-S249 ; ISSN 0923-7534

    مصطلحات موضوعية: Oncology, Hematology

    الإتاحة: https://doi.org/10.1016/j.annonc.2020.08.166Test
    https://api.elsevier.com/content/article/PII:S0923753420401620?httpAccept=text/xmlTest
    https://api.elsevier.com/content/article/PII:S0923753420401620?httpAccept=text/plainTest

    View record in BASE

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث